𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial

✍ Scribed by Christian R. Loehberg; Sebastian M. Jud; Lothar Haeberle; Katharina Heusinger; Gerhard Dilbat; Alexander Hein; Claudia Rauh; Peter Dall; Nadine Rix; Sabrina Heinrich; Stefan Buchholz; Benno Lex; Barbara Reichler; Boris Adamietz; Ruediger Schulz-Wendtland; Matthias W. Beckmann; Peter A. Fasching

Publisher
Springer US
Year
2010
Tongue
English
Weight
214 KB
Volume
121
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Strategies for the application of biomar
Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials
✍ Kapil Dhingra; Victor Vogel; Nour Sneige; Aysegul Sahin; Marcelo Aldaz; Gabriel πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 648 KB

Current chemoprevention trial designs based on epidemiological risk assessment and occurrence of cancer as an endpoint are inefficient and expensive. Novel biomarkers are needed to facilitate the development of chemopreventive interventions. The following four categories of biomarkers may be useful

Participation in a women's breast cancer
Participation in a women's breast cancer risk counseling trial: Who participates? Who declines?
✍ Barbara K. Rimer; Joellen M. Schildkraut; Caryn Lerman; Ting Hsiang Lin; Janet A πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 748 KB

## BACKGROUND. Little is known about what factors influence women to participate in trials designed for women at high risk for breast cancer. Yet the recruitment phase is of utmost importance in determining whether the trial can achieve its goals. The purpose of this study was to examine predictors